Geode Capital Management, LLC Lineage Cell Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,679,280 shares of LCTX stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,679,280

Previous 3,596,006 2.32%

Holding current value

$2.35 Million

Previous $3.6 Million 6.9%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.8 - $1.12 $66,619 - $93,266	83,274 Added 2.32%	3,679,280 $3.35 Million
Q2 2024 Aug 09, 2024	BUY	$0.89 - $1.47 $305,225 - $504,136	342,950 Added 10.54%	3,596,006 $3.6 Million
Q1 2024 May 13, 2024	BUY	$0.86 - $1.48 $272,830 - $469,522	317,245 Added 10.81%	3,253,056 $4.81 Million
Q4 2023 Feb 13, 2024	BUY	$0.91 - $1.35 $153,675 - $227,979	168,874 Added 6.1%	2,935,811 $3.2 Million
Q3 2023 Nov 13, 2023	BUY	$1.16 - $1.53 $401,509 - $529,577	346,129 Added 14.3%	2,766,937 $3.26 Million
Q2 2023 Aug 11, 2023	BUY	$1.26 - $1.53 $1.43 Million - $1.74 Million	1,138,808 Added 88.83%	2,420,808 $3.41 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $1.53 $21,109 - $26,914	17,591 Added 1.39%	1,282,000 $1.92 Million
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.5 $13,518 - $19,879	13,253 Added 1.06%	1,264,409 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$1.13 - $1.77 $2,015 - $3,157	1,784 Added 0.14%	1,251,156 $1.41 Million
Q2 2022 Aug 12, 2022	SELL	$1.12 - $1.61 $1.15 Million - $1.65 Million	-1,026,601 Reduced 45.11%	1,249,372 $1.97 Million
Q1 2022 May 13, 2022	SELL	$1.21 - $2.48 $65,555 - $134,361	-54,178 Reduced 2.33%	2,275,973 $3.5 Million
Q4 2021 Feb 11, 2022	SELL	$1.84 - $2.68 $20,907 - $30,452	-11,363 Reduced 0.49%	2,330,151 $5.71 Million
Q3 2021 Nov 12, 2021	BUY	$2.26 - $2.86 $6,621 - $8,379	2,930 Added 0.13%	2,341,514 $5.9 Million
Q2 2021 Aug 13, 2021	BUY	$2.17 - $3.0 $2.33 Million - $3.22 Million	1,072,633 Added 84.73%	2,338,584 $6.66 Million
Q1 2021 May 12, 2021	BUY	$1.77 - $3.1 $355,171 - $622,052	200,662 Added 18.84%	1,265,951 $2.97 Million
Q4 2020 Feb 12, 2021	BUY	$0.95 - $1.83 $41,557 - $80,053	43,745 Added 4.28%	1,065,289 $1.87 Million
Q2 2020 Aug 13, 2020	SELL	$0.71 - $1.18 $465,742 - $774,050	-655,975 Reduced 39.1%	1,021,544 $888,000
Q1 2020 May 14, 2020	BUY	$0.6 - $1.58 $65,275 - $171,891	108,792 Added 6.94%	1,677,519 $1.39 Million
Q4 2019 Feb 13, 2020	BUY	$0.54 - $1.01 $15,087 - $28,218	27,939 Added 1.81%	1,568,727 $1.4 Million
Q3 2019 Nov 12, 2019	BUY	$0.85 - $1.24 $1.31 Million - $1.91 Million	1,540,788 New	1,540,788 $1.51 Million

Others Institutions Holding LCTX

# of Institutions

121

Shares Held

94.2M

Call Options Held

63.8K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $109M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Lineage Cell Therapeutics, Inc. Transaction History